Virus News and Research

Latest Virus News and Research

Study finds extensive harassment of public health officials during first 11 months of the pandemic

Study finds extensive harassment of public health officials during first 11 months of the pandemic

17 Mar 2022
Two clever human antibodies can target Ebola and Sudan virus

Two clever human antibodies can target Ebola and Sudan virus

17 Mar 2022
KHN’s ‘What the Health?’: We may be done with covid, but covid’s not done with us

KHN’s ‘What the Health?’: We may be done with covid, but covid’s not done with us

17 Mar 2022
Omicron SARS-CoV-2 variant is more stable than its ancestral strain on smooth and porous surfaces

Omicron SARS-CoV-2 variant is more stable than its ancestral strain on smooth and porous surfaces

17 Mar 2022
Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

17 Mar 2022
Study reports thiopurines inhibit the replication of the betacoronaviruses HCoV-OC43 and SARS-CoV-2

Study reports thiopurines inhibit the replication of the betacoronaviruses HCoV-OC43 and SARS-CoV-2

17 Mar 2022
Narrative review reports two important mediators in SARS-CoV-2-induced ischemic stroke recovery

Narrative review reports two important mediators in SARS-CoV-2-induced ischemic stroke recovery

17 Mar 2022
Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

17 Mar 2022
MHRA authorizes new medicine for COVID-19 prevention

MHRA authorizes new medicine for COVID-19 prevention

17 Mar 2022
Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

17 Mar 2022
Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

17 Mar 2022
The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

17 Mar 2022
Researchers develop extraction-free saliva RT-LAMP assay for workplace surveillance of SARS-CoV-2

Researchers develop extraction-free saliva RT-LAMP assay for workplace surveillance of SARS-CoV-2

17 Mar 2022
Covid vaccination not linked to increased risk of rare neurological events

Covid vaccination not linked to increased risk of rare neurological events

17 Mar 2022
Risk of SARS-CoV-2 transmission from mother to baby is extremely low, say researchers

Risk of SARS-CoV-2 transmission from mother to baby is extremely low, say researchers

17 Mar 2022
Impact of COVID-19 measures on the future transmission of respiratory syncytial virus

Impact of COVID-19 measures on the future transmission of respiratory syncytial virus

17 Mar 2022
The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

17 Mar 2022
COVID-19-related hospitalizations in children below 18 years with influenza-associated hospitalizations

COVID-19-related hospitalizations in children below 18 years with influenza-associated hospitalizations

17 Mar 2022
Relationship between people’s subjective beliefs about risks and their private protective behaviors during the COVID-19 pandemic

Relationship between people’s subjective beliefs about risks and their private protective behaviors during the COVID-19 pandemic

17 Mar 2022
Lateral flow assays: The possibilities beyond COVID-19

Lateral flow assays: The possibilities beyond COVID-19

From nanoComposix 17 Mar 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback